Emicizumab |
Katalog-Nr.GC26147 |
Emicizumab is a bispecific monoclonal antibody, which connects activator IX and activator X to replace the function of missing activator VIII, thus restoring hemostasis. Emicizumab can be used in hemophilia A research.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1610943-06-0
Sample solution is provided at 25 µL, 10mM.
Emicizumab is a bispecific monoclonal antibody, which connects activator IX and activator X to replace the function of missing activator VIII, thus restoring hemostasis. Emicizumab can be used in hemophilia A research.
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *